Serum sST2/ miR-223 as a Dual Biomarker for Disease Activity & Clinical Efficacy of SLIT in HDM-Induced Allergic Rhinitis

Clinical trial NCT07436208 · COMPLETED

Trial details

NCT number: NCT07436208
Sponsor: Zagazig University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

HDM-Induced Allergic Rhinitis

Start date: 2025-02-01
Primary completion: 2025-05-30
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.